Guidelines of the Czech gastroenterological society – endoscopic treatment of Barrett´s esophagus and early esophageal neoplasia
Authors:
J. Martínek 1; Přemysl Falt 2
; J. Gregar 3; V. Procházka 3
; J. Špičák 1; O. Urban 2; S. Rejchrt 4; A. Pazdro 5; M. Zemanová 6; A. Hep 7; J. Malušková 8; M. Stefanová 9; M. Vieth 10; T. Jirásek 11; T. Hucl 1
Authors place of work:
Klinika hepatogastroenterologie, IKEM, Praha
1; Centrum péče o zažívací trakt, Vítkovická nemocnice a. s.
2; II. interní klinika UP a FN Olomouc
3; II. interní klinika LF UK a FN Hradec Králové
4; III. chirurgická klinika 1. LF UK a FN v Motole, Praha
5; Onkologická klinika 1. LF UK a VFN, Praha
6; Interní gastroenterologická klinika, FN Brno-Bohunice
7; Pracoviště klinické a transplantační patologie, IKEM, Praha
8; Interní oddělení, Nemocnice Na Františku, Praha
9; Klinikum Bayreuth, Department of Pathology, Preuschwitzer Str. 101, 95445 Bayreuth, Německo
10; Ústav patologie 3. LF UK a FN Královské Vinohrady, Praha
11
Published in the journal:
Gastroent Hepatol 2013; 67(6): 479-487
Category:
Summary
The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.
Submitted:
25. 11. 2013
Accepted:
2. 12. 2013
Zdroje
1. Hvid-Jensen F, Pedersen L, Drewes AM et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365(15): 1375–1383.
2. Martinek J, Benes M, Brandtl P et al. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study. Endoscopy 2008; 40(9): 711–716.
3. Spechler SJ, Sharma P, Souza RF et al. American Gastroenterological Association medical position statement on the management of Barrett´s esophagus. Gastroenterology 2011; 140(3): 1084–1091.
4. Bennett C, Vakil N, Bergman J et al. Consensus statements for management of Barrett´s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012; 143(2): 336–346.
5. Stahl M, Budach W, Meyer HJ et al. Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5): 46–49.
6. Curvers WL, ten Kate FJ, Krishnadath KK et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010; 105(7): 1523–1530.
7. Lim CH, Treanor D, Dixon MF et al. Low--grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy 2007; 39(7): 581–587.
8. Phoa KN, van Vilsteren RE, Pouw BL et al. Surveillance vs. RFA for Barrett´s esophagus with confirmed low-grade dysplasia: a European multicenter randomized controlled trial. DDW 2013; abstract 1004.
9. Komanduri S, Swanson G, Keefer L et al. Use of a new jumbo forceps improves tissue acquisition of Barrett´s esophagus surveillance biopsies. Gastrointest Endosc 2009; 70(6): 1072–1078.
10. Martinek J, Maluskova J, Stefanova M et al. Jumbo biopsy forceps improves adequate tissue sampling in patients with Barrett´s esophagus: final results of a randomized study. UEGW 2013; abstract 4821.
11. Evans JA, Early DS, Fukami N et al. The role of endoscopy in Barrett´s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 2012: 76(6): 1087–1094.
12. Lee JK, Cameron RG, Binmoeller KF et al. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett´s esophagus. Endoscopy 2013; 45(7): 571–574.
13. Stefanová M, Tučková I, Malušková J et al. Biopsie nejsou dostatečné pro přesnou diagnostiku neoplazie u pacientů s Barrettovým jícnem. Gastroent Hepatol 2013; 67(4): 264–270.
14. Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett´s esophagus with dysplasia. N Engl J Med 2009; 360(22): 2277–2288.
15. Phoa KN, Pouw RE, van Vilsteren FG et al. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: A Netherlands cohort study. Gastroenterology 2013; 145(1): 96–104.
16. Phoa KN, Pouw RE, Bisschops R et al. Radiofrequency ablation combined with endoscopic resection for Barrett´s esophagus with early neoplasia in 132 patients: results of a prospective European multicenter study (EURO-II). DDW 2013.
17. Vieth M, Ell C, Gossner L et al. Histological analysis of endoscopic resection specimens from 326 patients with Barrett´s esophagus and early neoplasia. Endoscopy 2004; 36(9): 776–781.
18. Vieth M, Stolte M. Pathology of early upper GI cancers. Best Pract Res Clin Gastroenterol 2005; 19(6): 857–869.
19. Martinek J, Stefanova M, Maluskova J et al. Radiofrequency ablation in patients with early esophageal neoplasia: a prospective evaluation of 52 consecutive cases. UEGW 2013.
20. Manner H, Pech O, Heldmann Y et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013; 11(6): 630–635.
21. Gockel I, Sgourakis G, Lyros O et al. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patiens. Expert Rev Gastroenterol Hepatol 2011; 5(3): 371–384.
22. Bergman JJ, Zhang YM, He S et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc 2011; 74(6): 1181–1190.
23. Higuchi K, Tanabe S, Azuma M et al. A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901). Gastrointest Endosc 2013; 78(5): 704–710.
24. Zhang YM, Boerwinkel DF, He S et al. Prospective feasibility study on the use of multiband mucosectomy for endoscopic resection of early squamous neoplasia in the esophagus. Endoscopy 2013; 45(3): 167–173.
25. Pouw RE, Bergman JJ. Radiofrequency ablation for Barrett´s esophagus, for whom and by whom? Clin Gastroenterol Hepatol 2013; 11(10): 1256–1258.
26. Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett´s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11(10): 1245–1255.
27. Gupta M, Iyer PG, Lutzke L et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett´s esophagus: results from a US Multicenter Consortium. Gastroenterology 2013; 145(1): 79–86.
28. Martínek J, Falt P, Gregar J et al. Radiofrekvenční ablace v gastrointestinálním traktu – aktuální stav ve světě a v ČR. Gastroent Hepatol 2011; 65(5): 279–285.
29. van Vilsteren FG, Phoa KN, Alvarez Herrero L et al. Circumferential balloon-based radiofrequency ablation of Barrett´s esophagus with dysplasia can be simplified, yet efficacy maintained, by omitting the cleaning phase. Clin Gastroenterol Hepatol 2013; 11(5): 491–498.
30. van Vilsteren FG, Phoa KN, Alvarez Herrero L et al. A simplified regimen for focal radiofrequency ablation of Barrett´s mucosa: a randomized multicenter trial comparing two ablation regimens. Gastrointest Endosc 2013; 78(1): 30–38.
31. Neuhaus H, Terheggen G, Rutz EM et al. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett´s esophagus. Endoscopy 2012; 44(12): 1105–1113.
32. van Vilsteren FG, Pouw RE, Herrero LA et al. Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program. Endoscopy 2012; 44(1): 4–12.
33. van Vilsteren FG, Alvarez Herrero L, Pouw RE et al. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study. Endoscopy 2012; 44(12): 1096–1104.
34. Pouw RE, Heldoorn N, Herrero LA et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc 2011; 73(4): 662–668.
35. Pech O, May A, Günter E et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett´s esophagus. Am J Gastroenterol 2006; 101(10): 2223–2229.
36. Fernández-Sordo JO, Konda VJ, Chennat J et al. Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett´s esophagus with early neoplasia? J Gastrointest Oncol 2012; 3(4): 314–321.
37. May A. Stop confusing us with EUS prior to endoscopic resection. Endoscopy 2008; 40(1): 71–72.
38. Griffin SM, Burt AD, Jennings NA. Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg 2011; 254(5): 731–736.
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2013 Číslo 6
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- Diagnosis of disorders of gastric emptying in diabetic patients with diabetic autonomic neuropathy
- Endoscopic resolution of refractory postoperative bile leak from bile duct with fully covered self-expandable metallic stent
- Guidelines of the Czech gastroenterological society – endoscopic treatment of Barrett´s esophagus and early esophageal neoplasia
- Hepatocellular carcinoma – our experience with surveillance, effect and complications of transarterial chemoembolization